NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,115 | -45.9% | 36,215 | +38.1% | 0.00% | 0.0% |
| Q2 2023 | $1,093,654 | -31.5% | 26,233 | -1.1% | 0.00% | -50.0% |
| Q1 2023 | $1,595,815 | +410.0% | 26,535 | +506.0% | 0.00% | – |
| Q4 2022 | $312,920 | -78.1% | 4,379 | -76.2% | 0.00% | -100.0% |
| Q3 2022 | $1,432,000 | +30.4% | 18,392 | +18.1% | 0.00% | 0.0% |
| Q2 2022 | $1,098,000 | -18.2% | 15,567 | +157.5% | 0.00% | +100.0% |
| Q2 2021 | $1,342,000 | +287.9% | 6,046 | +132.3% | 0.00% | – |
| Q1 2021 | $346,000 | -46.9% | 2,603 | -30.8% | 0.00% | -100.0% |
| Q4 2020 | $651,000 | +110.7% | 3,763 | +36.9% | 0.00% | – |
| Q3 2020 | $309,000 | -35.2% | 2,748 | -63.6% | 0.00% | -100.0% |
| Q2 2019 | $477,000 | +97.9% | 7,551 | +51.0% | 0.00% | – |
| Q1 2019 | $241,000 | – | 5,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |